Stay updated on Study of Factor VIIa Variant in Hemophilia: Clinical Trial
Sign up to get notified when there's something new on the Study of Factor VIIa Variant in Hemophilia: Clinical Trial page.

Latest updates to the Study of Factor VIIa Variant in Hemophilia: Clinical Trial page
- Check2 days agoChange DetectedThe NIH website-transition announcement banner is no longer displayed. The page continues to show a 403 error.SummaryDifference1%

- Check9 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the ClinicalTrials.gov record for the Marzeptacog Alfa hemophilia study, removing its study details and results information.SummaryDifference17%

- Check15 days agoChange DetectedA banner was added above the page announcing NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1. The study page continues to display a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the expected study record content. The additions show the 403 header and basic HTML structure, while the detailed study information previously visible on the page is no longer accessible.SummaryDifference17%

Stay in the know with updates to Study of Factor VIIa Variant in Hemophilia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Factor VIIa Variant in Hemophilia: Clinical Trial page.